QXO, Inc. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-0
Book Value Per Share
$16
Free Cash Flow Per Share
$0
Cash Per Share
$4
Revenue Per Share
$11
OCF Per Share
$0
Return on Equity
-3.8%
Return on Assets
-2.7%
Return on Invested Capital
-2.2%
Debt to Equity
0.31
Current Ratio
3.58
Quick Ratio
2.61
Asset Turnover
0.65
Days Sales Outstanding
61.09
Days Payables Outstanding
56.73
Days Inventory On Hand
103.71
Cash Conversion Cycle
108.07
SBC / Revenue
2.1%
Capex / Revenue
1.1%
Working Capital
$4.00B
Net Current Asset Value
$-634M
Invested Capital
$12.76B
OCF / Net Income
-0.94
FCF / Net Income
-0.66
Accruals Ratio (Sloan)
-3.4%
Net Debt
$696M
Net Debt / EBITDA
-5.09
Interest Coverage
-1.41
Cash Coverage
1.51
Dividend Coverage
4.87
Capex Coverage
3.34
Tangible Common Equity
$776M
TCE / Total Assets
4.9%
Goodwill / Total Assets
32.2%
NOPAT
$-194M
Cash ROIC
2.1%
WC / Revenue
58.4%
Capex / D&A
0.72
Reinvestment Rate
-4292.9%
Total Payout Ratio
0.0%
Asset Growth vs Revenue Growth
-11713.3%
Revenue 5Y CAGR
178.0%
EPS 5Y CAGR
32.7%
FCF 5Y CAGR
157.9%
EBITDA 5Y CAGR
Book Value 5Y CAGR
321.7%
Stock Price (FY-end)
$19
Market Cap
$11.82B
P/E Ratio
115.84
P/S Ratio
1.73
P/B Ratio
1.22
P/TB Ratio
15.23
P/OCF Ratio
45.24
P/FCF Ratio
64.55
Enterprise Value
$12.52B
EV / EBITDA
EV / Sales
1.83
EV / FCF
68.34
FCF Yield
1.5%
Dividend Yield
0.0%
Shareholder Yield
-1.2%
Buyback Yield
Capex Yield
0.7%
Dividend Per Share
$0
DPS YoY Growth
-94.7%
Operating Leverage
Graham Number
$9
Shares Variation (YoY)
200.5%
Beta (5Y)
0.72
Cost of Equity
8.1%
Cost of Debt (after tax)
4.5%
WACC
7.4%
ROIC - WACC Spread
-9.5%
52W High
$24
52W Low
$12
Trailing Return 1Y
24.0%
Trailing Return 5Y
4.6%
F-Score (Piotroski)
3.00
Z-Score (Altman)
1.79

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates

QXO, Inc. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes7.00%61.00%-3.00%5.00%10.70%2.60%
Foreign Rate Differential
Other Adjustments-3.00%0.00%-0.60%
Valuation Allowance Change0.00%6.00%1.00%5.00%-0.20%0.00%
Tax Law Change
Effective Tax Rate21.00%4.07%41.00%22.00%45.00%17.10%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$47.4K$178.0K−$192.2K−$297.0K$22.8M−$57.7M
Income Taxes Paid (Cash)$301.0K$38.2M

QXO, Inc. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Beacon Roofing Supply Inc.

Total Consideration

$10.79B

Share price: $124.35

Purchase-Price Allocation

Goodwill

$5.11B

Deferred Tax Liability

$910.3M

Pro-Forma Combined Entity

Revenue

$9.54B

Net Income

−$332.4M

Kodiak Building Partners

Total Consideration

$2.25B

Share price: $40.00

QXO, Inc. — RestructuringNEW

Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).

As of 2025-12-31

CategoryClassP&L ChargeCash PaidReserve Balance
Employee Severance And Employee Related CostsEmployee Severance+$55M$28M$26M
Stock Based Compensation ExpenseOther+$41M
Lease Abandonment CostsFacility Closing+$5M